Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required

A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.